Liver Disease Cirrhosis
Cirrhosis Regression in Chronic Hepatitis C: An Old Tale With a New Ending
Cirrhosis Regression in Chronic Hepatitis C This is a complex article, but worth reading. It seems to move the science from treating HepC as such to regression of the cirrhosis which makes sense as it is the cirrhosis that makes you feel like crap and it is the cirrhosis that will kill you. Craig Mallet…
Read MoreChronic Hepatitis C: Current Disease Management
Current Disease Management The hepatitis C virus (HCV) is one of the most important causes of chronic liver disease in the United States. It accounts for about 15 percent of acute viral hepatitis, 60 to 70 percent of chronic hepatitis, and up to 50 percent of cirrhosis-stage liver disease, and liver cancer. Of the U.S.…
Read MoreCan You Get Viral Hepatitis from Oral Sex?
Can You Get Viral Hepatitis from Oral Sex? Make sure you know the facts about how oral sex could transmit the three most common types of viral hepatitis. Please note: explicit descriptions of sexual activity are contained within this article. by Nicole Cutler, L.Ac. The education campaign following the AIDS epidemic of the 1980s has…
Read MoreAre You In Denial About Hepatitis C?
Are You In Denial About Hepatitis C? Denial is a logical response to a new Hepatitis C diagnosis. While being in denial has some practical uses, refusing to accept this liver disease can be harmful to you and your loved ones. by Nicole Cutler, L.Ac. Regardless of how long Hepatitis C has inhabited a liver,…
Read MoreAntiviral therapy in chronic Hepatitis C – A tightrope walk
Antiviral therapy in chronic Hepatitis C Hepatitis C virus (HCV) is a common cause of liver disease leading to liver cirrhosis, liver failure and hepatocellular carcinoma (HCC). Worldwide, HCV-related end-stage liver disease is the most common indication for liver transplantation. It is estimated that 170 million people are infected worldwide. Prevalence of HCV infection is…
Read More24-week hepatitis C treatment as effective as 48-week treatment
24-week hepatitis C treatment CHAPEL HILL, N.C. – A new multinational study finds that a 24-week treatment course for hepatitis C that adds telaprevir to peginterferon alfa and ribavirin is just as effective as a 48-week regimen for many patients. This is good news for up to 4 million people in the U.S. who suffer…
Read MoreCelebrating Valentines Day: A Sweet Treat for Hepatitis C
A Sweet Treat for Hepatitis C Upon first glance, the Valentine’s Day tradition of gifting chocolates may seem counterintuitive for someone with Hepatitis C. Though, research boasts two reasons why choosing the right kind of chocolate will show you care about your sweetheart’s liver health. by Nicole Cutler, L.Ac. Simply stepping into any grocery, drug…
Read More